Topical Gel study for Adults with NF1 & cNFs
NFlection Therapeutics | 2023
Phase two trial is done. A phase three trial may open soon. Latest update.
View ArticleNFlection Therapeutics | 2023
Phase two trial is done. A phase three trial may open soon. Latest update.
View Article
Ann & Robert H. Luries Childrens Hospital of Chicago
| 2023
By Carlos Prada, MD
Recruiting NF1 individuals with known Plexiform Neurofibromas
View Article
John Hopkins Medicine
| 2023
By Carlos Romo, MD
Children and teens 19 years and younger.Adults 40 years and over.
View Article
Massachusetts General Hospital/Harvard
| 2022
By Julie Brewer
University of Wisconsin-Milwaukee
| 2021
By Bonnie Klein-Tasman, PhD
© 2025 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.